Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01139996 · ClinicalTrials.gov registry record · Phase 4
Use of Transdermal Clonidine in Trauma Patients
A Phase 4 study, sponsored by Memorial Health University Medical Center.
- Terminated
- Registry status
- Phase 4
- Development phase
- 22
- Enrollment target
NCT01139996 is a Phase 4 study that was terminated before completion, run by Memorial Health University Medical Center. The registered enrollment target is 22 participants.
The verdict
NCT01139996, a Phase 4 study, was terminated before completion, sponsored by Memorial Health University Medical Center.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 22 participants
- Enrollment target
Study Summary
This study will attempt to learn how to better treat trauma patients with delirium who are on a breathing machine. Delirium, also known as acute, temporary brain dysfunction, is a common reason why ventilated patients can not be weaned from the breathing machine even though their lungs may be healthy enough to breathe without the machine. The study hopes to show that by decreasing the patient's delirium it will lead to quicker weaning from the breathing machine and possibly a quicker overall recovery as well. Patients enrolled in this study will be treated with Clonidine or placebo. Clonidine is a drug that produces significant calming effects, decreases anxiety, and reduces pain, but with a lower incidence of delirium than other medications used in the ICU for this purpose. Clonidine is not approved by the Federal Food and Drug Administration for treatment of delirium, but is commonly used for this purpose.
Interventions
- DRUG Placebo
- DRUG Clonidine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2010-05 |
| Est. Completion | 2012-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01139996
The ClinicalTrials.gov registry entry for NCT01139996 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Health University Medical Center, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01139996 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01139996 about?
NCT01139996 is a clinical study titled "Use of Transdermal Clonidine in Trauma Patients". This study will attempt to learn how to better treat trauma patients with delirium who are on a breathing machine. Delirium, also known as acute, temporary brain dysfunction, is a common reason why ventilated patients can not be weaned from the breathing machine even though their lungs may be health...
What is the current status of trial NCT01139996?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 22 participants. The study started on 2010-05. Estimated completion is 2012-08.
What interventions are being tested in trial NCT01139996?
The interventions under investigation include: Placebo (DRUG), Clonidine (DRUG).
Who is sponsoring clinical trial NCT01139996?
This trial is sponsored by Memorial Health University Medical Center, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.